| Name | Non-Dopaminergic Neurotransmitter Degeneration as Upstream Driver in Parkinson's Disease |
| Summary | Validation of non-dopaminergic system degeneration (noradrenergic, serotonergic, cholinergic, GABAergic) as upstream driver in PD, including iPSC-derived neuron vulnerability, CSF biomarker development, PET imaging, and clinical trials of multi-target intervention |
No comments yet. Be the first to comment!
No comments yet. Be the first to comment!